These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 19046187)

  • 1. Neurological aspects of hyperinsulinism-hyperammonaemia syndrome.
    Bahi-Buisson N; Roze E; Dionisi C; Escande F; Valayannopoulos V; Feillet F; Heinrichs C; Chadefaux-Vekemans B; Dan B; de Lonlay P
    Dev Med Child Neurol; 2008 Dec; 50(12):945-9. PubMed ID: 19046187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological aspects in hyperinsulinism-hyperammonaemia syndrome.
    Kelly A; Stanley CA
    Dev Med Child Neurol; 2008 Dec; 50(12):888. PubMed ID: 19046183
    [No Abstract]   [Full Text] [Related]  

  • 3. Spectrum of glutamate dehydrogenase mutations in Japanese patients with congenital hyperinsulinism and hyperammonemia syndrome.
    Aso K; Okano Y; Takeda T; Sakamoto O; Ban K; Iida K; Yamano T; Shintaku H
    Osaka City Med J; 2011 Jun; 57(1):1-9. PubMed ID: 22106762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system hyperexcitability associated with glutamate dehydrogenase gain of function mutations.
    Raizen DM; Brooks-Kayal A; Steinkrauss L; Tennekoon GI; Stanley CA; Kelly A
    J Pediatr; 2005 Mar; 146(3):388-94. PubMed ID: 15756227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterisation of glutamate dehydrogenase gene defects in Japanese patients with congenital hyperinsulinism/hyperammonaemia.
    Fujioka H; Okano Y; Inada H; Asada M; Kawamura T; Hase Y; Yamano T
    Eur J Hum Genet; 2001 Dec; 9(12):931-7. PubMed ID: 11840195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinism and hyperammonemia syndrome: report of twelve unrelated patients.
    De Lonlay P; Benelli C; Fouque F; Ganguly A; Aral B; Dionisi-Vici C; Touati G; Heinrichs C; Rabier D; Kamoun P; Robert JJ; Stanley C; Saudubray JM
    Pediatr Res; 2001 Sep; 50(3):353-7. PubMed ID: 11518822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy.
    Ceulemans BP; Claes LR; Lagae LG
    Pediatr Neurol; 2004 Apr; 30(4):236-43. PubMed ID: 15087100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intractable absence seizures in hyperinsulinism-hyperammonemia syndrome.
    Nakano K; Kobayashi K; Okano Y; Aso K; Ohtsuka Y
    Pediatr Neurol; 2012 Aug; 47(2):119-22. PubMed ID: 22759688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinsulinism and hyperammonaemia syndrome due to a novel missense mutation in the allosteric domain of the glutamate dehydrogenase 1 gene.
    Chik KK; Chan CW; Lam CW; Ng KL
    J Paediatr Child Health; 2008 Sep; 44(9):517-9. PubMed ID: 18928469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperinsulinism-hyperammonaemia syndrome: novel mutations in the GLUD1 gene and genotype-phenotype correlations.
    Kapoor RR; Flanagan SE; Fulton P; Chakrapani A; Chadefaux B; Ben-Omran T; Banerjee I; Shield JP; Ellard S; Hussain K
    Eur J Endocrinol; 2009 Nov; 161(5):731-5. PubMed ID: 19690084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperinsulinism/hyperammonemia syndrome: insights into the regulatory role of glutamate dehydrogenase in ammonia metabolism.
    Stanley CA
    Mol Genet Metab; 2004 Apr; 81 Suppl 1():S45-51. PubMed ID: 15050973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and genetic diagnosis of Dravet syndrome: report of 20 cases].
    Siegler Z; Neuwirth M; Hegyi M; Paraicz E; Pálmafy B; Tegzes A; Barsi P; Karcagi V; Claes L; De Jonghe P; Herczegfalvi A; Fogarasi A
    Ideggyogy Sz; 2008 Nov; 61(11-12):402-8. PubMed ID: 19070316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperinsulinism and hyperammonaemia syndrome and severe myoclonic epilepsy of infancy.
    Pérez Errazquin F; Sempere Fernández J; García Martín G; Chamorro Muñoz MI; Romero Acebal M
    Neurologia; 2011 May; 26(4):248-52. PubMed ID: 21163222
    [No Abstract]   [Full Text] [Related]  

  • 14. Brain MRI findings in severe myoclonic epilepsy in infancy and genotype-phenotype correlations.
    Striano P; Mancardi MM; Biancheri R; Madia F; Gennaro E; Paravidino R; Beccaria F; Capovilla G; Dalla Bernardina B; Darra F; Elia M; Giordano L; Gobbi G; Granata T; Ragona F; Guerrini R; Marini C; Mei D; Longaretti F; Romeo A; Siri L; Specchio N; Vigevano F; Striano S; Tortora F; Rossi A; Minetti C; Dravet C; Gaggero R; Zara F
    Epilepsia; 2007 Jun; 48(6):1092-6. PubMed ID: 17381446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of epilepsy in terminal 1p36 deletion syndrome.
    Bahi-Buisson N; Guttierrez-Delicado E; Soufflet C; Rio M; Daire VC; Lacombe D; Héron D; Verloes A; Zuberi S; Burglen L; Afenjar A; Moutard ML; Edery P; Novelli A; Bernardini L; Dulac O; Nabbout R; Plouin P; Battaglia A
    Epilepsia; 2008 Mar; 49(3):509-15. PubMed ID: 18031548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperinsulinemic hypoglycemia: think of hyperinsulinism/hyperammonemia (HI/HA) syndrome caused by mutations in the GLUD1 gene.
    Tran C; Konstantopoulou V; Mecjia M; Perlman K; Mercimek-Mahmutoglu S; Kronick JB
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):873-6. PubMed ID: 25781533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical evaluation of an infant with hypoglycemia resulting from a novel de novo mutation of the GLUD1 gene and hyperinsulinism-hyperammonemia syndrome.
    Balasubramaniam S; Kapoor R; Yeow JH; Lim PG; Flanagan S; Ellard S; Hussain K
    J Pediatr Endocrinol Metab; 2011; 24(7-8):573-7. PubMed ID: 21932603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel missense mutations outside the allosteric domain of glutamate dehydrogenase are prevalent in European patients with the congenital hyperinsulinism-hyperammonemia syndrome.
    Santer R; Kinner M; Passarge M; Superti-Furga A; Mayatepek E; Meissner T; Schneppenheim R; Schaub J
    Hum Genet; 2001 Jan; 108(1):66-71. PubMed ID: 11214910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The three stages of epilepsy in patients with CDKL5 mutations.
    Bahi-Buisson N; Kaminska A; Boddaert N; Rio M; Afenjar A; Gérard M; Giuliano F; Motte J; Héron D; Morel MA; Plouin P; Richelme C; des Portes V; Dulac O; Philippe C; Chiron C; Nabbout R; Bienvenu T
    Epilepsia; 2008 Jun; 49(6):1027-37. PubMed ID: 18266744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myoclonic absence epilepsy with photosensitivity and a gain of function mutation in glutamate dehydrogenase.
    Bahi-Buisson N; El Sabbagh S; Soufflet C; Escande F; Boddaert N; Valayannopoulos V; Bellané-Chantelot C; Lascelles K; Dulac O; Plouin P; de Lonlay P
    Seizure; 2008 Oct; 17(7):658-64. PubMed ID: 18321734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.